Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression

C Yi, Y Wang, C Zhang, Y Xuan, S Zhao, T Liu, W Li… - Cancer letters, 2016 - Elsevier
Abstract Overexpression of cyclooxygenase 2 (COX-2) is frequently found in early and
advanced lung cancers. However, the precise regulatory mechanism of COX-2 in lung …

[HTML][HTML] Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation

W Chen, W Guo, M Li, D Shi, Y Tian, Z Li, J Wang, L Fu… - PloS one, 2013 - journals.plos.org
Cleavage and polyadenylation specific factor 4 (CPSF4), a member of CPSF complex, plays
a key role in mRNA polyadenylation and mRNA 3′ ends maturation. However, its possible …

PC-SPES down-regulates COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cells

T Ikezoe, Y Yang, T Saitoh… - International …, 2006 - spandidos-publications.com
Aberrant expression of COX-2 occurs in many types of malignancies including colon and
lung cancers, and is implicated in development and progression of cancer. The molecular …

[HTML][HTML] Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT

Q Yang, W Fan, Z Zheng, S Lin, C Liu, R Wang… - … et Biophysica Acta (BBA …, 2019 - Elsevier
CPSF4 was identified as a crucial tumorigenic factor in lung cancer development. However,
its precise function and the underlying molecular mechanisms in colon cancer progression …

[HTML][HTML] hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers

Y Xuan, J Wang, L Ban, JJ Lu, C Yi, Z Li, W Yu, M Li… - Molecular Oncology, 2016 - Elsevier
Abstract Cyclooxygenase-2 (COX-2) is highly expressed in tumor cells and has been
regarded as a hallmarker for cancers, but the excise regulatory mechanism of COX-2 in …

Identification of COX17 as a therapeutic target for non-small cell lung cancer

C Suzuki, Y Daigo, T Kikuchi, T Katagiri, Y Nakamura - Cancer research, 2003 - AACR
We have been investigating gene expression profiles in non-small cell lung cancers
(NSCLCs) to identify molecules involved in pulmonary carcinogenesis and select which …

CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer

YQ Song, K Sun, LL Gong, LL Shi, T Qin, SS Wang… - Medical Oncology, 2022 - Springer
Lung cancer is the leading cause of malignant tumor-related deaths worldwide. The
presence of tumor-initiating cells in lung cancer leads to tumor recurrence, metastasis, and …

[HTML][HTML] The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2

S Lu, Y Yang, Y Du, L Cao, M Li, C Shen, T Hou… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract Cyclooxygenase-2 (COX-2) is overexpressed in a variety of human epithelial
cancers, including lung cancer, and is highly associated with a poor prognosis and a low …

[HTML][HTML] Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer

W Li, W Yue, H Wang, B Lai, X Yang… - Oncology …, 2016 - spandidos-publications.com
The objective of the present study was to investigate whether cyclooxygenase-2 (COX-2) is
associated with malignancy, and to investigate its molecular mechanisms in human lung …

[HTML][HTML] Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer

H Luo, Z Chen, H Jin, M Zhuang, T Wang, C Su… - Journal of experimental …, 2011 - Springer
Background Vascular endothelial growth factor (VEGF) expression is up-regulated via a
cyclooxygenase-2 (COX-2)-dependent mechanism in non-small cell lung cancer (NSCLC) …